Trial intelligence / Profile preview

PRX167700 in Knee Osteoarthritis

NCT01945346Phase 2Completed

Sponsor
Proximagen
Start
Sep 2013
Primary completion
Apr 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of PRX167700 in osteoarthritis (OA), sponsored by Proximagen. Started Sep 2013; status: completed.

02

Drugs

PRX167700
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT01945346.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01945346.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call